View in EDS HTML Full Text PDF Full Text

Obinutuzumab is effective for the treatment of rituximab-refractory PLA2R-associated membranous nephropathy.

Saved in:
Bibliographic Details
Title: Obinutuzumab is effective for the treatment of rituximab-refractory PLA2R-associated membranous nephropathy.
Authors: Su, Wenyan1,2 (AUTHOR), Li, Jianyi3 (AUTHOR), Men, Jinzhao3 (AUTHOR), Zhong, Shuo2 (AUTHOR), Wang, Yunzhao4 (AUTHOR), Zhang, Yao1 (AUTHOR), Xu, Liang1 (AUTHOR), Gao, Jie1 (AUTHOR), Liu, Dan5 (AUTHOR), Wang, Rong1 (AUTHOR), Sun, Jing1,2 (AUTHOR), Wang, Haiping1,2 (AUTHOR)
Source: Clinical Kidney Journal. May2025, Vol. 18 Issue 5, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20488505
DOI:10.1093/ckj/sfaf026